Home/Filings/4/0001104659-23-098959
4//SEC Filing

Luptakova Katarina 4

Accession 0001104659-23-098959

CIK 0001840233other

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 4:26 PM ET

Size

5.3 KB

Accession

0001104659-23-098959

Insider Transaction Report

Form 4
Period: 2023-09-05
Luptakova Katarina
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-09-05+106,000106,000 total
    Exercise: $2.79Exp: 2033-09-04Common Stock (106,000 underlying)
Footnotes (1)
  • [F1]The option was granted on September 5, 2023 and will vest in equal monthly installments beginning on October 1, 2023 through September 1, 2027.

Issuer

Xilio Therapeutics, Inc.

CIK 0001840233

Entity typeother

Related Parties

1
  • filerCIK 0001991149

Filing Metadata

Form type
4
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 4:26 PM ET
Size
5.3 KB